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CHAPTER I 
INTRODUCTION 
It has been known that 3-hydroxy-3-methyl glutaryl coenzyme A 
reductase is the key enzyme for controlling cholesterol synthesis. 
This enzyme catalyzes the conversion of HMG-CoA to mevalonic acid. 
Cholesterol in excessive amounts can be lethal as in cholesterolemia, 
arteriosclerosis and coronary artery disease. 
Experiments with mammalian tissue have shown that this enzyme is 
regulated by diets, hormones, and other factors and exhibits a diurnal 
rhythm. Also studies on solubilization techniques and purification 
have been done. 
Little research has been done on this important enzyme in turkey 
liver and in plants. The objectives of this study were as follows: 
1) to solubilize HMC:-CoA reductase from turkey liver microsomes, 2) to 
study some partially purified HMC:-CoA reductase from turkey liver 
microsomes and, 3) to establish the presence of HMG-CoA reductase 
activ.tty in spinach chloroplast. 
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CHAPTER II 
LITERATURE REVIEW 
A. Cholesterol Biosynthesis 
The study in vivo of Schoenheimer and Breusch in 1933 (1) 
provided the first evidence of cholesterol synthesis, absorption 
and destruction in an intact animal. In 1933, Rittenberg and 
Schoenheimer (2) showed that a rapid increase in isotopically 
labelled cholesterol was observed when deuterium (D20) was fed to 
animals for long periods of time. Siperstein (3) has reviewed the 
synthesis of cholesterol from acetate. Bucher and McGarrahan (4) 
concluded that the biosynthesis of cholesterol from acetate 
in vitro requires both microsomes and soluble cell constituents 
and in vivo over 90% of newly formed cholesterol is in the microsomal 
fraction. The synthesis of radioactive mevalonic acid synthesized 
from l-14C acetate in rat liver homogenates was first demonstrated 
by Knauss, Porter and Wasson (5). 
The work of Block, Lynen, Cornforth and Popjak (6) led to the 
elucidation of the biosynthetic pathway of cholesterol from acetate. 
The first step of the pathway is the conversion of HMG-CoA to 
mevalonate. HMG-CoA reductase converts HMG-CoA to mevalonic acid. 
The enzyme was first found in mammalian microsomes by Bucher, 
Overath and Lynen (7). This enzyme has also been found in yeast 
2 
3 
(8, 9). Mevalonate is phosphorylated to 5-phosphomevalonate, 5-
phosphomevalonate is phosphorylated to 5-pyrophosphomevalonate, and 
5-pyrophosphomevalonate is decarboxylated to isopentenyl pyrophosphate. 
An isomerization, with loss of 4-5 3 H from mevalonate (2-R3 H of iso-
pentenyl pyrophosphate), was observed in the formation of dimethylallyl 
pyrophosphate. A head to tail condensation of isopentenyl pyrophos-
phate and dimethylallyl pyrophosphate results in the formation of the 
acyclic monoterpene pyrophosphate (Figure 1). 
B. Regulation of Cholesterol Biosynthesis 
There is a significant amount of evidence to support the belief 
that the rate of cholesterol synthesis from acetate is regulated at 
the site of action of HMG-CoA reductase. This regulation is accom-
plished by many factors such as 1) cholesterol feeding, 2) fasting, 
3) compounds present in bile, 4) hormones, 5} x-rays, 6) time of 
day, 7) and cyclic rhythm (10). 
1. Regulation by Cholesterol Feeding and 
Fasting 
In fasted rats, the hepatic HMG-CoA reductase activity was 
depressed dramatically when compared to hepatic HMG-CoA reductase 
activity in rats injected with triton WR 1339; this was first observed 
by Bucher et al. (7). Siperstein and Fagan (11) used a gas liquid 
chromatography to compare the amount of MVA formed and the amount 
of B-hydroxy-6-methyl glutaric acid formed in rats fed cholesterol; 
from these experiments they concluded that the control step was the 
reduction of HMG-CoA to MVA. The first direct evidence for reduction 
HMG~CoA + 2NADPH + H+ 1 MVA + 2NADP+ 
MVA + ATP 2 MVAP + ADP 
MVAP + ATP 3 rWAPP + ADP 
MVAPP + ATP 4 IPP + C0 2 + ADP + PI 
IPP 5 D~1APP 
IPP + DMAPP 6 GERANYL PYROPHOSPHATE + 
1 HMG-CoA REDUCTASE 
2 MEVALONATE KINASE 
3 PHOSPHOMEVALONATE KINASE 
4 PYROPHOSPHOMEVALONATE DECARBOXYLASE 
5 ISOPENTENYL PYROPHOSPHATE ISOMERASE 
6 GERANYL PYROPHOSPHATE SYNTHETASE 
Figure 1. The Pathway From Mevalonic Acid To Acyclic Monoterpene 
Pyrophosphate 
4 
PPI 
of liMC:-CoA reductase activity in microsomal preparations and solubil-
ized fractions by cholesterol feeding and fasting in rats was reported 
by Linn (12). Experimentation on cholesterol fed rats by Shapiro and 
Rodwell (13) suggested that cholesterol affects the rate of sterol 
synthesis by changing the amount of enzyme, not the activity. 
5 
Dietschy and Siperstein (14) studied the effect of cholesterol 
feeding and fasting on sterol synthesis in seventeen tissues of the 
rat. They observed a difference between the biosynthetic pathway for 
sterols in hepatic tissue and the biosynthetic pathway in extrahepatic 
tissues. Only the liver responds to exogenous cholesterol and fasting. 
Tn turkey liver and kidney, HMG-CoA reductase activity was suppressed 
with a 1% cholesterol diet (15). 
2. Regulation by Dietary Fats 
Feeding shorter chain fatty acids to rats cause a greater lowering 
in HMG-CoA reductase activity than to feeding longer chain fatty acids. 
A higher degree of unsaturation also causes the lower activity (16). 
3. Regulation by Factors Present in 
Bile and Hormone 
Bile contains many substances including bile acids, phospholipids 
and cholesterol. Hamprecht and Lynen (7) demonstrated that choles-
terol synthesis is suppressed by feeding bile acids to rats. However, 
these bile acids play no direct role in the control of sterol synthesis 
by the liver; in fact, suppression of cholesterol synthesis actually 
resulted from the change in the enterolyrnphatic circulation of 
endogenous cholesterol (18). 
6 
There Is evldenee to show thnt hormones are involved in the 
lll:tinll·naJwc• or :1 diurnal rhythm of reductase activity and overall 
regulation of cholesterol synthesis. These include epinephrin, 
norepinephrin, glucocorticoid, insulin, glycagon and triiodothyro-
nine (11). Both insulin and thyroid hormone increased HMG-CoA 
reductase activity (19). Physiological doses of insulin and glucagon 
first stimulated and then inhibited the cholesterol synthesis from 
labelled acetate in rat liver in vivo. This group also reported 
that an influence of insulin on cholesterogenesis in rat liver is 
controversial (20). Guder et al. (21) demonstrated the dependence 
of HMG-CoA reductase upon the thyroid state of the animal and the 
stimulation of this enzyme by thyroid hormone given in vivo. Gluca-
gon, which is an antagonist of the action of insulin and triiodothy-
roxine, blocked the increase in activity initiated by these hormones. 
Hydrocortisone prevented both hormonally-induced and diurnal increase 
in reductase activity (11). Epinephrine and norepinephrine stimulated 
reductase activity, but steroid sex hormones, like estrogens, proges-
terone and androgen, suppressed reductase activity (22, 23). 
A diurnal rhythm in HMG-CoA reductase was first noted in mouse 
liver by Kandutsch and Saucier (24), and shortly after that was found 
in rat liver (17, 25), rat intestine (26), certain rat and mouse 
hepatoma (27), and in turkey liver and kidney (15). The work on the 
mechanism of diurnal variation of hepatic HMG-CoA reductase activity 
suggested that the diurnal variation in enzyme is at least due to a 
change in rate of synthesis (28). Rat liver microsomal HMG-CoA 
reductase exhibited a cyclic rhythm with a peak activity at midnight 
(13) but it is the opposite of HMG-CoA reductase activity in turkey 
7 
ll ver which showed the hi~hest pe;Jk at noon (15). This is directly 
related to the feeding habits of the anim;il. Turkeys eat the bulk of 
~ 
their meal before noon. 
Of the enzyme catalyzing the conversion of acetate to squalene, 
only one other enzyme in the cholesterol metabolic pathway, choles-
terol 7-a-hydroxylase was known to have a diurnal rhythm. This 
enzyme catalyzes the first reaction in the catabolism of cholesterol 
to bile acids (10). The effect of fasting and refeeding of fat-free 
diets on HMG~CoA reductase showed a significant diurnal variation 
(29). 
The developmental pattern of rat hepatic HMG-CoA reductase 
showed a sharp rise immediately prior to birth and exhibit an equally 
precipitous postnatal decline. The activity remained constant close 
to normal adult levels for the first 8 days, then declined and 
remained low prior to weaning. By the third day after weaning, 
reductase activity increased by three-fold and did not decline to 
the adult value until the second week after weaning (10). One 
observation on the neo-natal developmental pattern of HMG-CoA 
reductase from the liver of turkey poults showed maximum activity 
at 18 days old (15). The changes of HMG-CoA reductase in rat 
brain during development was first increased between 8 and 12 days 
after birth followed by a fall until 18 days (30). 
C. Enzymic Reduction of HMG-CoA to Mevalonate 
The enzyme 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase 
(mevalonate:NADP oxidoreductase[acylating CoA] E.C. 1.1.1.34) which 
catalyzes the reduction of 3-hydroxy-3-methyl-glutaryl-CoA to 
mevalonic acid is considered to be the rate-limiting factor in the 
biosynthesis of cholesterol from acetate. Guder et al. (23) 
fractionated microsomal suspension into smooth membrane and rough 
membrane by a sucrose gradient technique and suggested that the 
localization of this enzyme was in the rough membrane of endoplasmic 
rcticult~. Shapiro and Rodwell upon using a discontinuous sucrose 
gradient confirmed Guder's results that the rough membrane contained 
over 95% of HMG-CoA reductase (13). By using continuous sucrose 
gradients Goldfarb (13) indicated that over 80% of the activity 
was found in the fraction of smooth membranes composed of smooth 
endoplasmic reticulum, golgi apparatus and plasma membrane. 
Mitropoulous' (32) experiments suggested that HMG-CoA reductase 
was in the membrane of endoplasmic reticulum, very similar to those 
in which cholesterol 7-a-hydroxylase is present, but with a 
relatively higher load of ribosome. In rat brain, HMG-CoA reductase 
is not exclusively microsomal (30). In yeast system, most of the 
activity of HMG-CoA reductase exi'sts in the mitochondria (33, 34). 
Suzuki (35) presented evidence that HMG-CoA reductase was located 
in mitochondria and not in the microsomal or supernatant fraction 
in both fresh and cut sweet potato root tissues, but in diseased 
tissue the enzyme was locallized in microsomes. Arebalo (36) 
reported that there is an HMG-CoA reductase activity in cell-free 
extract of both leaf and callus tissue, and in chloroplasts of 
Nepcta cataria. 
Purification and investigation of the properties of liver 
HMC-CoA reductase have been very difficult because the enzyme is 
bound to microsomal membrane. Various procedures have been tried 
8 
to solubilize this enzyme from rat liver microsomes. Siperstein used 
deoxycholate but did not show any purification (37). Linn (38) 
solublllzed llM<:-coA reductase by extracting acetone powders from rat 
liver. According to Rudney and Kawachi (37), crude microsomal 
preparations treated with 0.25% sodium deoxycholate was the only 
procedure which provided soluble enzyme preparation. After solubili-
zation of the enzyme followed with DEAE-cellulose, hydroxyapatite 
9 
and Sephadex G-200 chromatography, HMG-CoA reductase could be purified 
up to 320 fold, and it showed the same properties as the enzyme in 
the yeast system. 
Brown in 1973 (39) solubilized the enzyme from rat livers by 
'3 methods: 1) by using snake venom treatment, 90% of HMG-CoA reductase 
was released, 2) prolonged incubation with 4 M KCl, the enzyme was 
released during a 24 hour-period, and 3) freezing and glycerol 
extraction, 69% of HHG-CoA reductase was released when 50% glycerol 
was used in a medium. The soluble enzyme was purified up to 130 
folds. Heller and Gould (40) described the solubilization technique 
by slow freezing and thawing. About 80% was solubilized. Higgins 
et al. (41) observed that the specific activity of the most pure 
Kawachi-Rudney preps were relatively low when compared to the preps 
according to Brown et al. {39) and Heller and Gould (40). Ackerman 
and Redd (42) modified the technique of Linn (38) by extraction with 
buffer and lyophilizing. 
HMG-CoA reductase activity is increased by preincubation with 
NADPH, and this effect has been utilized for purifying HMG-CoA 
reductase because this form does not bind to hydroxyapatite (43). 
Tormanen et al. (44) developed a simple rapid purification method 
by using affinity chromatography, and obtained a 975-fold purifi-
cation. Schrewberry (45) reported a purification of HMG-CoA 
reductase using slow freeze-thawed for solubilization, a 17-fold 
increase in activity by using (NH 4 )2S0 4 , a 139-fold from agarose, 
and a 350-fold increase from Sephadex. This enzyme was reversibly 
inactivated at temperatures below 19°. The behavior of this 
partially purified enzyme on Bio-Gel A appears to be unusual. 
Multiple forms of the enzyme differing in M.W. were observed. A 
report (46) which compared the enzyme activity from normal rats 
and rat treated with cholestyramine showed that cholestyramine 
treatment produced an increase in concentration of this enzyme. 
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Blue Dextran/Sepharose-4B affinity chromatography showed that HMG-CoA 
reductase from rat livers can be purified up to 2,747-fold, and it was 
estimated to be 93% pure based upon spectrophotbmetric scans of 
polyacrylamide gels. 
A comparison 9f the enzyme using liver microsomes of rat 
and chicken from the four methods was performed as follows: 
1) freeze-thaw technique, 2) slow freeze-thaw technique, 3) deter-
gent extraction and 4) sanification technique. The slow freeze-thaw 
procedure produced the higher specific activity (47). 
HMC-CoA reductase is the first membrane bound enzyme reported 
to show reversible cold lability. Heller and Gould (48) showed that 
soluble HMC:-coA reductase was inactivated reversibly by cold but 
the microsomal enzyme did not show any cold sensitivity. From this 
observation he proposed that the enzyme can exist in two forms, a 
cold inactivated and a heat activated form. HMG-CoA reductase 
that was solubilized by Brown (39) was irreversibly inactivated at 
4°C. In contrast, HMG-CoA reductase that was solubilized by the slow 
freeze-thaw methods was reversibly inactivated at 4°C. Tormanen et 
al. (49) concluded that rapid irreversible inactivation is caused by 
11 
a factor or factors present in crude soluble extract, which is non-
dialyzable and is destroyed by heat. This result suggested that the 
inactivation factor is a protein. Beg et al. (50) found that liver 
HMG-CoA reductase is diminished when cAMP is added to a microsome, and 
the preincubation of unwashed rat liver microsomes with MgATP reduced 
HMG-CoA reductase activity. The time course of inactivation of HMG-
CoA reductase by MgATP was shown by Shapiro et al. (51). Inactivation 
of liver HMG-CoA reductase by Mg+ 2 and ATP in vitro is completely 
reversed by an activator. The activator and in~ctivator both occur 
in the liver cytosol. The inactivator is also present in the liver 
microsomes. Modulation of reductase activity by interconversion of 
active and inactive forms appear to be a feasible mechanism for the 
regulation of reductase in vivo (52). 
Bell et al. (53) reported on the inhibition of HMG-CoA reductase 
by pure cholesterol and oxygenated cholesterol in hepatoma tissue 
culture cells. ML-236B which is a fungal metabolite which has been 
isolated from cultures of Penicillium citrinum (52) is a competitive 
inhibitor of HMG-CoA reductase (53). Brown et al. (54) reported 
that compactin (ML-236B) increased the cellular content of HMG-CoA 
reductase in extracts of human fibroblasts. From these observations, 
it was suggested that when the activity of HMG-CoA reductase is 
profoundly inhibited in intact cells, the cells responded by in-
creasing the synthesis of the HMG-CoA reductase enzyme. HMG-CoA 
reductase has also been isolated and purified from Fusarium oxysporum 
12 
(55). 
HMG-CoA reductase and HMG-CoA synthase were shown to be regu-
lated in the adrenal gland of the rat (27); whereas, plasma cholesterol 
level was lowered by administration of 4-aminopyrolopyrimiaine causing 
the synthase and reductase to increase. The subsequent intravenous 
infusion of low density lipoprotein restored the plasma cholesterol 
level and suppressed synthase and reductase activity in parallel (56). 
Lin (57) reported the conditions for achieving the steady state of 
3-hydroxy-3-methylglutaryl-CoA reductase in culture rat liver cells, 
and they also found that dexamethasone and hydrocortisome increased 
HMG-CoA reductase activity of a glucacon decreased the activity. 
CHAPTER III 
MATERIALS AND METHODS 
A. Materials 
l. Plants 
Fresh spinach (Spinacia oleracea) was purchased from a local 
grocery store. 
2. Animals 
Turkey hens (4-16 weeks of age) were fed on tallow diet or corn 
oil diets (15). The turkeys were kept in a room with lights on from 
6:00 a.m. to 6:00 p.m. and lights off from 6:00 p.m. to 6:00 a.m. 
The turkeys were sacrificed between 8:00 a.m. - 12:00 noon. The 
livers were removed and used immediately. 
3. Radioactive Compounds 
DL-3[Glutaryl-3- 14 C]-hydroxy-3-methylglutaryl coenzyme A (ID1G-CoA) 
and DL-5- 3 H(U) mevalonic acid were purchased from New England Nuclear, 
Boston, Massachusetts. The HMG-CoA was obtained as an aqueous solu-
tion, pH 5.0 with a specific activity of 49.5 millicuries per milli-
mole. The 5- 3 H mevalonate was obta~ned as the dibenzoyl-ethylenediamine 
salt with a specific activity of 5.00 curies per millimole. 
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4. Enzymes, Substrates and Cofactors 
Glucose-6-phosphate dehydrogenase was purchased from Sigma 
Chemical Company, St. Louis, Missouri. Glucose-6-phosphate as the 
disodium salt, NADP+ as the sodium salt and NADPH as tetrasodium 
salt wer-e pur-chased from Sigma Chemical Company, St. Louis, Missouri. 
5. Chemicals and Reagents 
14 
Solvents and reagents were of analytical grade or of the highest 
quality available unless otherwise specified. Insta-gel was purchased 
from Packard Instrument Company Inc., Downers Grove, Illinois. Whatman 
number one phase separation paper from Curtin Matheson Scientific Inc. 
Affi-Gel Blue (100-200 mesh) was purchased from Bio-Rad Laboratories, 
Richmond, California. 
B. Methods 
I. Preparation of Microsomes 
The turkeys wer-e sacrificed and the livers were removed, placed 
on ice, and used immediately. The whole turkey liver was weighed, 
minced with scissors, and then homogenized in a loose fitting Potter-
Elvehjem glass tissue grinder with a motor driven, groved teflon pestle 
in buffer A (2 ml/gram of tissue) containing 0.1 M sucrose, 0.05 M KCl, 
0.04 M KlhPO,., 0.03 M EDTA and 1 mM dithiothreitol at pH 7.2, according 
to procedure described by Heller and Gould (40). The homogenate was 
centrifuged twice at 10,000 x g for 15 min, and t~e pellet was discard-
ed. The supernatant was centrifuged for one hour at 100,000 x g and 
the pellet was resuspended in one-third of the original amount of 
huffl'r tlwt wns used. This suspension was centrifuged again at 
100,000 x g for o1w hour. 'l'he pellet wns removed and assayed for 
enzyme netivity (Figure 2). The resulting microsomal pellet was 
transferred to a pyrex tube and frozen in a dry ice-ethanol bath 
and stored at -20°C. 
2~ Chloroplast Isolation 
15 
Chloroplasts were isolated by the method of R. G. Jensen and J. A. 
Bassham (58). · 
3. Assnys 
llM<:-CoA reductase activity was measured by two radioactive assays. 
The first was the adaption of the method by Huber et al. (59). The 
reaction contained 10 mM glucose-6-phosphate, 1 mM NADP+, glucose-6-
phosphate dehydrogenase (2 units), 1 mM EDTA, 1 mM dithiothreitol, 
0.1 M potassium phosphate buffer, pH 7.4, 100 microgram of protein and 
3-14C HMG-CoA (; 8.0 x 104 dpm). The reaction was performed in a 
total volume of 1.0 ml. The reaction mixture was incubated at 37°C 
for one hour. 5-:- 3 H mevalonic acid (:: 23-25 x 105 dpm/100 J.ll) was 
added as an internal standard. The reaction was stopped by quick 
free:dng in a dry ice-ethanol bath and 200 JJl of 2N H2S04 was added. 
The reaction mixture was allowed to stand at room temperature for 10 
minutes in order for lactonization of mevalonate to occur. Anhydrous 
sodium sulfate (6 gm} was mixed with the reaction mixture. After 
standing for one hour at room temperature, the samples were extracted 
four times with diethyl ether (1 x 9 ml, 3 x 5 ml). 
The combined e~tracts were evaporated to dryness in a hot water-
HoMOGENATE 
CENTRIFUGE AT 10~000 X G~ 15 MIN 
PELLET 
(DISCARDED) 
SUPERNATANT 
PELLET 
(DISCARDED) 
CENTRIFUGE AT 10~000~ 
15 MIN 
SUPERNATANT 
CENTRIFUGE AT 
100~000 X G~ 
1 HOUR 
PELLET SUPERNATANT 
(DISCARDED) 
MICROSOMAL PELLET 
RESUSPEND 
IN 1/3 OF 
ORIGINAL BUFFER~ 
CENTRIFUGE AT 100~000 
X G~ 1 HOUR 
SUPERNATANT 
Figure 2. Microsomal Preparation from Turkey Liver 
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bath. One residue was dissolved in 1.0 ml of water, placed on a 
Dowex-1 formate column (0.5 x 5 em) and eluted with 5.0 ml of water. 
The eluate, which contained the mevalonolactone was collected in a 
scintillation vial. Only 2.0 ml of the eluate was added to 5.0 ml 
of Insta-gel. The sample was counted in a Packard PL scintillation 
spectrometer. 
A second assay was based on a method by Ackerman et al. (60) with 
some modifications. The reaction mixture contained 2 rnM NADPH, 20-30 
~g of Protein, and buffer A which contained 0.1 M sucrose, 0.05 M KCl, 
0.04 M KH2P0 4, 0.03 M EDTA and 1 rnM dithiothreitol. The samples were 
preincubated at 37°C for 30 min. 30 ~1 of DL-[3- 14C]HMG-CoA (~ 7.9-
8.9 x 104 dpm/10 ~1) was added to each sample, and incubated for 
20 min at 37°C. The total incubation volume was 200 ~1. 
The enzyme reaction was stopped by the addition of 1 ml of 2 N 
3 . 5 HCl, followed by the addition of 100 pl of 5- H-MVA (2.3-2.5 x 10 
dpm). The 3 H-MVA served as an internal reference. The samples were 
allowed to stand overnight at 4°C for lactonization. Each sample was 
then transferred to a glass scintillation vial, and the small 
incubation test tube was rinsed with 2 ml of buffer a followed by 
the addition of 2.3 gm of an equal molar mixture of solid K2HP04-
KH2P04. The samples were incubated at 37°C for 30 min. 
Chloroform (6 ml) was added, followed by vigorous shaking of the 
mixture by hand 2-3 times for 10-15 sec. The pressure was then 
released and the mixture was poured onto a fluted Whatman 1 PS phase 
separation filter. The chloroform extract was filtered through the 
phase separating fi!ter and was collected in a scintillation counting 
vial. The aqueous material that was retained on the filter, was then 
transferred with a pasteur pipette back into the original extraction 
vial and a 6 ml quantity of chloroform was added, followed by shaking 
and filtering as described above. The second chloroform filtrate was 
combined with the firJt chloroform filtrate. The aqueous phase was 
discarded. 
A saturated solution (1 ml) of equal molar KH2PO,.-K2HPO,. was 
added to the vial and was shaken vigorously, then the contents were 
poured onto a fresh l PS phase separating fluted filter. The chloro-
form filtrate was eollected in a scintillation counting vial. 
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The chloroform filtrate was evaporated to dryness under a stream 
of nitrogen. Water (3 ml) was added, and 2 ml of filtrate was added 
' to 4 ml of Insta-gel. The scintillation vial was counted in a Packard 
PL scintillation spectrometer. The blank need to be subtracted from 
the sample. 
4. Protein 
Protein concentration was determined by a modification of the 
Lowry procedure as described by Hartree (61) using bovine serum 
albumin as a standard. 
s. Solubilization Techniques 
Slow freezing and thawing. The freshly prepared microsomal 
pellet was frozen in a dry ice-ethanol bath by reducing temperature at 
the rate of 5-l0°C per min down 20-30°C, and then was frozen and left 
overnight at -20°C. Soluble enzyme was prepared the following day. 
One pellet was then thawed, suspended in buffer, and centrifuged 
at 100,000 x g for one hour and the supernatant was removed for assay. 
This supernatant is a crude soluble extract (41). 
Snluhilb:atlon by Salt._ The freshly prepared microsomal pellet 
waH 1nt·uhated al room temperature In buffer A containing 4 M KCl for 
24 hours, and then centrifuged at 100,000 x g for 60 min. The 
supernatant was removed for assay (40). 
6. Partial Purification of HMG-CoA Reductase 
Preparation I: The crude soluble extract by the solubilization 
technique of Heller and Gould.(40) w~s brought to 30% saturation (170 
g/1) with ammonium sulfate and centrifuged at 20,000 x g for 10 
minutes. The 30% ammonium sulfate supernatant was brought to 75% 
saturation by addition of (310 g/1) of ammonium sulfate to the 30% 
saturated solution and centrifuged at 20,000 x g for 10 minutes. 
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The 75% pellet was resuspended in buffer, incubated at 37°C with 
2 mM NADPH for 30 minutes, followed by heating at 60°C for 10 minutes, 
and then immediately cooled with ice. The heat-treated solution was 
centrifuged at 27,000 x g for 15 minutes at room temperature. The 
supernatant was removed and assayed for HMG-CoA reductase activity 
(Figure 3). 
The 100,000 x g pellet (Figure 4) was solubilized by slow freezing 
method as described by Heller and Gould (40). NADPH was added to this 
crude soluble extract to give a concentration of 2 mM. This soluble 
extract with NADPH was incubated at 37°C for 30 min, followed by 
heating at 65°C for 8 min, and then cooleq immediately in an ice-bath. 
The heat extract was centrifuged at 27,000 x g for 15 min at room 
temperature. 
The heat-treated supernatant (~ 3 mg) was applied to an Affi-Gel 
CRUDE SOLUBLE EXTRACT 
j 
30% <NH 4 ) 2S04 
20)000 X G) 10 MIN 
1-----
30% SUPERNATANT 30% PELLET 
j 
75% <NH 4 ) 2S04 
20)000 X G) 10 MIN 
r ______ _1__1 
75% SuPERNATANT 75% -PELLET 
j HEAT TREATMENT 
HEAT TREATMENT 
SUPERNATANT 
Figure 3. Partial Purification by Ammonium Sulfate 
Fractionation 
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PELLET 
MICROSOMAL PELLET 
1) THAW SLOWLY IN WATER BATH (~20°C) 
UNTIL SUSPENSION JUST THAWED, 
2) HOMOGENIZE THE PELLET WITH BUFFER A 
WITH MOTOR DRIVEN TEFLON PESTLE. 
3) CENTRIFUGE AT 100~000 X G FOR 1 HOUR, 
CRUDE SoLUBLE ExTRACT 
l 
ADD NADPH 
(DISSOLVE IN BUFFER A 
TO GIVE CONC, 2 MM) 
ACTIVATED BY HEATING AT 
3t>C FOR 30 MIN 
HEAT IN A WATER BATH 
AT 65°C FOR 8 MIN 
COOL RAPIDLY AT ROOM TEMP, 
IN AN ICE BATH 
CENTRIFUGE AT 27 1 000 X G 
FOR 15 MIN AT 20°C 
PELLET HEAT TREATMENT 
(DISCARD) SUPERNATANT 
Figure 4. Heat Treatment 
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Blue affinity column (0.5 x 5 em) which has been equilibrated and 
washed with buffer A overnight. The Affi-Gel Blue column was eluted 
with 4.5 ml of buffer A, 3 ml of buffer A + 0.2 M KCl and finally 
with 40 ml of buffer A + 0.5 M KCl. A total of ten fractions of 4 ml 
were collected. Fraction 3 to 8 were pooled and concentrated using a 
pressure dialysis Amicon Diaflo membrane which had been washed with 
buffer A containing 2 mM NADPH. HMG-CoA reductase activity was 
determined (Figure 5). 
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Preparation II. The same as Figure 4 and 5 but the crude soluble 
extract was solubilized by incubation with 4 M KCl over 24 hours and 
centrifuged for 100,000 x g for one hour. This is classified as the 
crude soluble extract. 
CRUDE SoLUBLE ExTRACT 
l(fiGURE 4) 
HEAT TREATED SUPERNATANT 
1 
APPLY 1~2 ML TO THE GEL CHROMATOGRAPHY 
1~ BuFFER A <4~5 ML) 
2 I . BuFFER A + I 2 r·1 KCL (3 ML) 
31 BUFFER A + 15 M KCL (40 ML) 
1 
COLLECT 10 FRACTIONS 4~5 ML 
1 
CONCENTRATE FRACTION 3 TO 8 WITH PRESSURE DIALYSIS 
Figure 5. Partial Purification of HMG-CoA Reductase from 
Turkey Liver 
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CHAPTER IV 
RESULTS AND DISCUSSION 
A. Animals 
When the procedure as described in Figure 2 was used to obtain a 
microsomal preparation, HMG-CoA reductase appeared to be loosely 
bound to the microsomal membrane (Table I). Washed microsomes have 
less activity than the supernatant. However, HMG-CoA reductase 
activity is never completely removed from the microsomes. 
Washed Microsomal Pellet 
2nd 100,000 x g 
supernatant 
(based upon the 
first assay) 
TABLE I 
MICROSOMAL PREPARATION 
protein 
mg/ml 
8.20 
4.20 
24 
specific activity 
nmoles MVA/mg/hr 
3.55 
5.57 
1. Preparation of Soluble HMC.-CoA Reductase 
All the puhlished techniques that have been used to solubilize 
HMG-CoA reductase were performed on the microsomal pellet. One of 
these techniques, which is very simple for effective solubilization 
of membrane-bound HMG-CoA reductase, is the slow freeze-thaw method 
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as described by Heller and Gould (40). This technique avoids using 
detergents which inhibit enzy~e activity and have to be removed before 
activity can be measured. The enzyme ID1G-CoA reductase from liver 
microsomes showed a decrease in activity after storing it more than 
one week at 4°C. Even though the soluble form as prepared by the 
freeze-thaw method showed an increase in activity when compared to 
the microsomal suspension, it is not very stable on storage. Whereas 
the soluble enzyme was completely destroyed when stored overnight at 
4°C, but microsomal pellets can be stored overnight without losing 
activity. Over 80% of ID1G-CoA reductase activity was solubilized 
from liver microsomes by this method. 
HMG-CoA reductase can be solubilized more than 90% by incubation 
with buffer A + 4 M KCl for 24 hours at room temperature as described 
by Brown et al. (39). 4 M KCl stabilized the enzyme over 24 hours 
(Table II). 
2. Partial Purification of HMG-CoA Reductase 
Preparation I: Purification based on solubilization by the slow 
freeze-thaw method was the first step. The crude soluble extract was 
fractionated by ammonium sulfate (Figure 3). Ammonium sulfate seemed 
to do nothing for the purification of HMG-CoA when compared to the 
~t:U~¢:J51il,SJomal Fl?·ell?et 
:·Mi-ttl.)~;SJOma 1 SSnt~p.!el'llS.ion 
· :G-r.!Ud~e SS-rlb)lb.l:e PR:xtreac.t 
;'R-E!Jllet 
:.n,~gll"e'e .:of ::sctLt!Ib.:ii.li:z;a_tfon 
·(.%) 
TABLE II 
SSQLUBI1IZ!.T::Il0NCOF TURKEY LIVER HMG-CoA REDUCTASE 
.':s1o'W r fEee~e-l::thaw method 
;;~:-pec.ific aac:: ti:i:vi tYa 
ob'y ~f.±l'st ::assay 
";Q .330 
0.'3·4 
-o.;Js 
'0 •. 06 
':8:6 ~'7·6 
'fi · · a cspec1 c act1v1ty 
by second assay 
11.19 
35.76 
5.37 
86.94 
Incubation with buffer A + 4 M KCl 
specifk activitya 
by -first assay 
3.22 
4.20 
1-3.77 
1.08 
92.73 
specific activitya 
by second assay 
6.24 
6.69 
24.30 
.51 
97.94 
::aq.p•e<iif:ic ;\A:dti'li:itt-y Un:irts 'Cfr'e •'giVen :rn :wanCJ.tnool'es of mevalonate formed per mg of protein per hour at 37 °C. 
N 
0\ 
rat liver enzyme (40) which could be purified up to 9 fold. Thus 
efforts to purify HMG-CoA reductase from turkey liver with ammonium 
sttlfatc were unsuccessful (Table III). 
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As seen in Figure 4, NADPH was added at 37°C to the crude soluble 
extract in order to activate turkey liver HMG-CoA reductase and stabil-
ize it during a heat step, which did increase the activity (Table IV). 
Figure 5 shows the elution profile from an affinity column of Affigel-
Blue. The ionic strength was increased by using buffer A, followed by 
buffer A+ .2 M KCl and finally with buffer A+ .5 M KCl. HMG-CoA 
reductase activity was in fraction 3 to 10. Partially purified HMG-CoA 
reductase as reported in Table IV, had a specific activity of 186 
nmoles MVA forned mg- 1 hr- 1 , an increase in specific activity of only 
17 fold. 
Preparation II: Purification was based on solubilization by 
incubation with buffer A + 4 M KCl. NADPH was added at 37°C to the 
crude soluble extract in order to activate and stabilize HMG-CoA 
reductase. HMG-CoA reductase retains 90% of its activity when heated 
in the presence of NADPH for 8 min at temperature up to 65°C and more 
than SO% of the. protein contaminants are denatured and precipitated. 
HMG-CoA reductase had a specific activity of 2.9 nmoles MVA formed/mg 
of protein/hr after the heat-treated sample was applied to the affinity 
column and concentrated in fractions 3 to 8. It is likely that the 
high salt concentration tended to alter the enzyme by changing the 
structural conformation so that the enzyme was no longer able to bind 
to the column. Therefore,the results from Table V showed no purifica-
tion after applying to the Affi-Gel Blue column. 
TABLE III 
PARTIAL PURIFICATION OF HMG-CoA REDUCTASE FROM TURKEY LIVER BY A}~fONIL~ SULFATE 
Volume Enzyme. Total Activity Protein Specific Yield Activity (ml) (units/ml) (unitsa) mg/ml Activityb (%) 
Freeze-thaw supernatant 25 7.02 176 2.70 2.60 100 
Soluble extract 22 5.54 122 1. 73 3.20 69 
0-30% Pellet 20 4.82 96 1.65 2.92 55 
0-30% Suspension 3 4.74 14 1.60 2.96 8 
30-75% Pellet 5 4.62 23 1.60 2.89 13 
30-75% Suspension 18 .03 <1 .28 .11 <1 
Heat treated supernatant 4 3.09 12 1.36 2.27 7 
This data was based upon the first assay. 
aOne unit of enzyme activity is defined as the formation of one nanomole of mevalonic acid per hour at 
37°C 
bSpecific activity units are given in nanomoles of mevalonate formed per mg of protein per hour at 37°C 
N 
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TABLE IV 
PARTIAL PURIFICATION OF HMG-CoA REDUCTASE FROM TURKEY LIVER USING FREEZE-THAW FOR SOLUBILIZATION 
Volume Enzyme 
(ml) Activity (units/ml) 
Total Protein Specific Yield Purifi-Activity (mg/ml) Activityb (%) cation (units8 ) (fold) 
Freeze-thaw 25 251 6266 22.40 11 100.00 1 
suspension 
Crude soluble 18 89 1609 2.50 36 25.68 3 
extract 
Pellet 3 112 335 20.80 5 5.30 <1 
Heat-treated 18 114 2048 2.40 47 32.68 4 
supernatant 
Affi-Gel Blue 3 24 73 .13 186 1.16 17 
concentration 
This data was based upon the second assay. 
aOne unit of enzyme activity is defined as the formation of one nanomole of mevalonic acid per hour at 
37°C 
bSpecific Activity Units are given in nanomoles of mevalonate formed per mg of protein per hour at 37°C 
N 
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TABLE V 
PARTIAL PURIFICATION OF HMG-CoA REDUCTASE FROM TURKEY LIVER USING·4 M KCl FOR SOLUBILIZATION 
Volume Enzyme Total Protein Specifi1, Purification Yield 
(ml) Activity Activity (mg/ml) (fold) (%) (units/ml). (unitsa) Activity 
4 M KCl Suspension 10 16.48 164 8.00 2.06 1.00 100.00 
Crude soluble 8 19.00 152 1.90 10.00 4.85 92.23 
extract 
Heat treated 3.30 7.86 25.94 .85 0.25 4.49 15.74 
supernatant 
Affi-Ge1 Blue 2 .29 .58 .10 2.90 1.40 <1 
concentrate 
fraction 3 to 8 
This data was based upon the second assay. 
aOne unit of enzyme activity is defined as the formation of one nanomole of mevalonic acid per hour at 
39°C 
bSpecific Activity Units are given in nanomoles of mevalonate formed per mg of protein per hour at 37°C 
(....) 
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B. Plants 
1. Chloroplast Isolation 
Whole chloroplasts were isolated by a method of Bassham and 
Jensen (58). Spinach leaves were washed, chilled and the midribs 
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were removed. Leaf tissue was blended with a Waring blender (3 times 
for 5 seconds each) in solution A, which contained basic stock 
solution (.33 M Sorbitol, 2 mM NaN0 3 , 2 mM EDTA, 2 mM sodium ascorbate, 
1 ~1 MnCl 2 , 1 mM MgC1 2 , .6 H2 0 and .5 mM K2 HP0 4 ), .50 mM MES (pH 6.1) 
and 0.2 M NaCl, and then passed through six layers of cheesecloth. 
The leaf homogenates were centrifuged at 2000 x g for 50 seconds. 
Whole chloroplasts were identified by light microscopy. The 2000 x g 
pellet was resuspended in 1 ml of solution B which contained the 
basic stock solution, .OS M HEPES (pH 6.7) and 0.2 M NaCl, and was 
homogenized with a pyrex glass tissue homogenizer, then assayed for 
HMG-CoA reductase activity. The specific activity of the homogenized 
chloroplasts was 0.16 ± 0.06 nmoles MVA formed/mg of protein/hr. The 
activity of the enzyme depended upon the freshness of leaves, which 
varied because they were purchased from the grocery store. 
C. Comparison of the Two Assay Systems 
13-Hydroxy-13-methyl glutaryl-CoA reductase (HMG-CoA reductase) 
catalyzed the reduction of NADPH of HMG-CoA to mevalonate. The first 
assay (60) involved a coupled assay which used glucose-6-phosphate 
dehydrogenase to convert glucose-6-phosphate and NADP+ to gluconolac-
tone-6-phosphate and NADPH, respectively. The second assay used NADPH 
directly. A high concentration of protein (up to 100 ].lg) was used, 
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but only ~ 80,000 dpm of 3- 14 C-I~<:-CoA was used in the first assay. 
However, the second assay used a high concentration of substrate and 
also a smaller amount of enzyme protein (20-30 ~g/assay). 
The first assay was incubated for 15 minutes, initiated by the 
addition of substrate and finally terminated after one hour. This 
first assay used anhydrous Na 2 S0 4 solidified when added to tpe re-
action mixture. Dowex-1 formate was used for the separation of 
mevalonolactone from the substrate. 
The second assay was preincubated for 30 minutes and assayed 
for 20 minutes. This second assay used an equal molar mixture of 
K2 HP0 4 -KH 2 P0 4 and chloroform for extraction. The mixture was poured 
onto a fluted Whatman 1 PS phase separatory filter. This paper 
separated ~G which was dissolved in aqueous buffer and mevalono-
lactone which dissolved in chloroform. The specific activity 
determined by the second assay was higher than the first method 
when the same tissue protein was used (Table VI). The difference 
between the two assays was the extraction and separation procedure. 
The second assay extracted more mevelonolactone than the first assay. 
Perhaps the solidified sodium sulfate prevented a good extraction 
of mevalonolactone. The first assay which used Dowex-1-formate to 
separate the substrate, HMG-CoA, from mevalonolactone was more 
effective than the second assay which used a Whatman 1 PS phase 
separator. The blank of the second assay was found to have high 
' 
activity whereas the blank of the first assay showed insignificant 
activity. This suggests that t~e phase separation technique which 
is faster is not more efficient and it should only be used as a 
method for quick assays of many samples. 
TABLE VI 
COMPARISON OF THE TWO ASSAY SYSTEMS 
Freeze-thaw 
Supernatant 
Soluble extract 
Specific Activityaby 
the First Assay 
2.55 
9.05 
Heat treated supernatant 10.59 
Specific Activitlby 
the Second Assay 
28.80 
75.00 
78.30 
a Specific. Activity Units are given in nanomoles of mevalonate formed 
per mg of protein per hour at 37°C 
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CHAPTER V 
SUMMARY 
3-Hydroxy-3-methylglutaryl coenzyme A reductase, the major 
regulatory enzyme in hepatic cholesterol biosynthesis, has been 
solubilized and partially purified from turkey liver microsome. 
The l~G-CoA reductase can be removed from turkey liver microsomes 
by exposing them to high salt concentrations, and a freeze-thaw 
treatment. No detergents are required. Exposing the microsomes 
to a freeze-thaw treatment solubilized more than 80% of the enzyme 
and the high salt concentration solubilized more than 90% of the 
microsomal HMG-CoA reductase activity. Subsequently, a 17 fold 
purification has led to an enzyme preparation with a specific activity 
of 186 nmoles MVA formed per mg of protein per hour by using a freeze-
thaw technique, heat treatment and affinity gel chromatography. 
The enzyme is also present in isolated spinach chloroplasts 
demonstrated by these experiments with spinach chloroplasts. Since 
there was no fractionation of spinach chloroplasts protein, it is 
difficult to conclude where HMG-CoA reductase is located. At best it 
could be suggested that HMG-CoA reductase might be somewhat bound to 
chloroplast thylakoid membranes. 
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